Skip to content

All recalls FDA

FDADrugsRecalled Status: Closed by the agency

NATCO Pharma Limited recalls Lansoprazole Delayed-Release Capsules USP

Class IIofficial

FDA Class II

FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.

Hazard
CGMP Deviations: Inadequate induction sealing on bottles, capsules were observed with bubbles on band seal, capsules with holes and spheres sticking to capsules. Also coding details were missing on one bottle.
Products
  • Lansoprazole Delayed-Release Capsules USP
Where it was sold

Nationwide in the USA

Nationwide

Units affected
4260 bottles
About this recall
Lansoprazole Delayed-Release Capsules USP, 15 mg, 14-count bottle, Manufactured by: Natco Pharma Limited Kothur- 509 228, India, Distributed by: Rising Pharma Holdings, Inc. East Brunswick, NJ. 08816. NDC 16571-742-41